Sweat Gland Diseases
5
0
0
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
6 treatments under study, led by Glycopyrronium 24 Medicated Cloth
Research Leaders
7 sponsors active, led by Virginia Clinical Research, Inc.
Related Conditions
Often studied with 9 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 5 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (5)
Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect?
An Open Label Study for Palmar Hyperhydrosis
The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes
A Minimally Invasive Surgery for Axillary Osmidrosis: Combined Liposuction With Subcutaneous Pruning
Umbilical Cord Blood-derived Mesenchymal Stem Cells in Regeneration of Sweat Glands and Body Repair
Research Network
Common Treatments
- Glycopyrronium 24 Medicated Cloth1
- Ucb Mesenchymal Stem Cells Treatment1
- Minimally Invasive Surgery1
- Liraglutide1
- Oxybutynin1
Active Sponsors
- Virginia Clinical Research, Inc.1
- Samantha Rodrigues Camargo Neves de Moura1
- Science Valley Research Institute1
- Tang-Du Hospital1
- Chinese PLA General Hospital1
Top Investigators
Eastern Virginia Medical School
Chinese PLA General Hospital
Department of Plastics and Burns, Tangdu Hospital
Virginia Clinical Research, Inc.
Science Valley Research Institute
Related Conditions
- Hyperhidrosis2
- Skin Diseases2
- Autonomic Agents1
- Autonomic Nervous System Diseases1
- Oxybutynin1